Histopathological analysis reveals mild to moderate changes in BALB/c mice after short-term administration of a microemulsion loaded with epoxy-α-lapachone
Authors:
- Luiz Filipe Gonçalves-OliveiraLGLuiz Filipe Gonçalves-Oliveira
- Juliana Figueiredo PeixotoJPJuliana Figueiredo Peixoto
- Bernardo Acácio Santini PereiraBPBernardo Acácio Santini Pereira
- Nathalia Silva Carlos OliveiraNathalia Silva Carlos Oliveira
- Davyson de Lima MoreiraDMDavyson de Lima Moreira
- Franklin Silva-SouzaFSFranklin Silva-Souza
- Carlos Roberto AlvesCarlos Roberto Alves
Open Access
- 31 October 2025
- journal article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 144, 105006
Abstract
No abstract availableKeywords
Funding Information
- Coordination for the Improvement of Higher Education Personnel
- National Council for Scientific and Technological Development (305287/2023-0)
- National Council for Scientific and Technological Development (152770/2024-0)
- National Council for Scientific and Technological Development (441634/2024-9)
- Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (E-26/201.654/2021)
- Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (E-26/203.931/2024)
- Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (E-26/010.000983/2019)
This publication has 11 references indexed in Scilit:
- Efficacy of the treatment using a microemulsion loaded with epoxy-α-lapachone in combination with meglumine antimoniate against murine infection by Leishmania (Leishmania) amazonensisInternational Journal for Parasitology: Drugs and Drug Resistance, 2024
- Epoxy-a-lapachone in nanosystem: a prototype drug for leishmaniasis assessed in the binomial BALB/c - Leishmania (Leishmania) amazonensisMemórias do Instituto Oswaldo Cruz, 2024
- Development of a microemulsion loaded with epoxy-α-lapachone against Leishmania (Leishmania) amazonensis murine infectionInternational Journal of Pharmaceutics, 2023
- Epoxy-α-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2H-naphtho[2,3-b]pyran-10,2′-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasitesThe Brazilian Journal of Infectious Diseases, 2023
- Treatment options for leishmaniasisClinical and Experimental Dermatology, 2021
- Potential Use of Microbial Surfactant in Microemulsion Drug Delivery System: A Systematic ReviewDrug Design, Development and Therapy, 2020
- The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensisInternational Journal for Parasitology: Drugs and Drug Resistance, 2019
- Influence of surfactin on physical and oxidative stability of microemulsions with docosahexaenoic acidColloids and Surfaces B: Biointerfaces, 2017
- Evidence for Tissue Toxicity in BALB/c Exposed to a Long-Term Treatment with Oxiranes Compared to Meglumine AntimoniateBioMed Research International, 2017
- Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New WorldActa Tropica, 2011